New yeast infection pill could stop repeat episodes
NCT ID NCT03561701
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new oral medication, oteseconazole, to see if it can prevent recurrent yeast infections in women who have had at least three infections in the past year. Over 400 participants took either the study drug or a placebo for 12 weeks after an initial treatment, and were followed for 48 weeks. The goal was to see if the drug could reduce the number of repeat infections.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT VULVOVAGINAL CANDIDIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
31204
Homestead, Florida, 33030, United States
-
31215
Phoenix, Arizona, 85032, United States
-
31217
Los Angeles, California, 90057, United States
-
31218
Jackson, Tennessee, 38305, United States
-
31222
Englewood, Ohio, 45322, United States
-
31223
Winston-Salem, North Carolina, 27103, United States
-
31227
Little Rock, Arkansas, 72212, United States
-
31229
Columbus, Ohio, 43231, United States
-
31232
Frisco, Texas, 75035, United States
-
31233
North Bay Village, Florida, 33141, United States
-
31240
Hartford, Connecticut, 06105, United States
-
31244
Columbus, Ohio, 43213, United States
-
31245
Hagerstown, Maryland, 21740, United States
-
31255
Wichita, Kansas, 67226, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.